Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
American Journal of Medical Genetics. Part A|April 27, 2004
Severe subacute GM2 gangliosidosis caused by an apparently silent HEXA mutation (V324V) that results in aberrant splicing and reduced HEXA mRNABrandy A Wicklow, Jennifer L Ivanovich, Margot M Plews, et al.Behaviour Research and Therapy|June 24, 2025
Female veterans with military sexual trauma history and posttraumatic stress disorder display impaired fear extinction learningSeth D Norrholm, Jenna L Laymon, Michelle Szewczuk, et al.The Journal of Pediatrics|February 18, 2014
Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarctionMichael M Dowling, Michael J Noetzel, Mark J Rodeghier, et al.Annals of Neurology|March 28, 2020
Predicting Recovery and Outcome after Pediatric Stroke: Results from the International Pediatric Stroke StudyRyan J Felling, Mubeen F Rafay, Timothy J Bernard, et al.American Journal of Hematology|October 15, 2013
Parent education and biologic factors influence on cognition in sickle cell anemiaAllison A King, John J Strouse, Mark J Rodeghier, et al.Journal of Biomolecular Screening|April 17, 2015
Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4)Emery Smith, Peter Chase, Colleen M Niswender, et al.Journal of Medicinal Chemistry|August 23, 2014
Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380)Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.Stroke|April 23, 2019
Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke ManagementKristin P Guilliams, Fenella J Kirkham, Susanne Holzhauer, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2013
Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanismThomas M Bridges, Jerri M Rook, Meredith J Noetzel, et al.Molecular Pharmacology|August 7, 2012
Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationshipsKaren J Gregory, Meredith J Noetzel, Jerri M Rook, et al.Pageof 10